This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Veterinary Cell-based Therapy Development
Cell-based veterinary therapy is an emerging treatment modality that has surfaced in recent years and holds the potential to address numerous currently untreatable diseases, such as genetic diseases and tumors, through a distinctive and potent mode of action. BioVenic offers solutions to scientists globally to tackle various challenges encountered in veterinary cell-based therapies and actively advocates for their thorough preclinical development. This includes identifying suitable cell sources, producing viable, effective, and safe cell products to cater to the unique requirements of ill individuals and specific diseases, and establishing scalable manufacturing processes. Our veterinary cell therapy development team excels in cutting-edge basic research and technology driven by next-generation engineering methods, including genome and epigenome editing, synthetic biology, and the utilization of biomaterials to transform target cells and innovate culture systems. We aim to be the most proficient and dependable partner for researchers working on cell-based veterinary treatments, assisting them in overcoming challenges at every stage, whether allogeneic or autologous.
Fig.1 Veterinary Cell Therapy Development.
Veterinary Cell-based Therapy Development Services
BioVenic categorizes its veterinary therapy development services related to animal cells based on cell sources and types, effectively meeting the technical requirements of scientific researchers in this field.
- Classification by Cell Source
Autologous Cell Therapy Development
BioVenic is focused on developing autologous cell therapies for veterinary use. By manipulating, expanding, processing, and re-implanting cells, we help create innovative solutions for treating incurable degenerative diseases in animals. Autologous cells are less likely to cause complications due to immune rejection and are simpler to use than other technologies in the field of regenerative medicine. Our strong background in cell and molecular biology allows for easy implementation of therapy development and preclinical evaluation.
Allogeneic Cell Therapy Development
BioVenic is skilled in the culture and modification of various tool cells suitable for veterinary allogeneic cell therapy development. Allogeneic cells make tool cells more accessible, and therapy protocols more standardized and universal. Our professional R&D team can assist you in achieving large-scale in vitro cell culture, directed differentiation, and survival status monitoring. We help in developing powerful and effective processes to meet downstream requirements.
Xenogeneic Cell Therapy Development
BioVenic offers preclinical program development and customization services for researchers interested in veterinary xenogeneic cell therapy. Xenogeneic cell therapy holds the most promising prospects and is considered the ultimate goal of cell therapy, yet it also encounters numerous challenges and difficulties. We incorporate various advanced technology platforms to address the scientific hurdles in veterinary xenogeneic therapy development, including immune rejection, viral infection, and cell degeneration, to guarantee the seamless advancement of our customers' projects.
- Classification by Cell Type
BioVenic specializes in utilizing the primary functional cells of cell therapy to create tailored services for engineering projects involving various stem cells, immune cells, and extracellular vesicles derived from stem cells. Our team of experts possesses extensive experience in researching animal immune cells and stem cells. We have developed standardized technical procedures for managing and transforming these cells at a molecular biology level, ensuring high service quality and efficiency in the development of veterinary cell therapy.
Comparison of Veterinary Cell Therapy from Different Cell Sources
| Cell Source | Cell Type | Immune Response | Cell Engraftment | Durability of Response |
| Autologous |
|
|
|
|
| Allogeneic |
|
|
|
|
| Xenogeneic |
|
|
|
|
Why Choose Us?
Innovation in Cell Engineering
BioVenic combines multiple animal cell engineering biological operations with cell therapy development to create a new generation of personalized cell therapy solutions.
Mastery of Various Cells
BioVenic has a comprehensive understanding of the biological background of animal functional cells that have been utilized or have potential applications. We can fulfill customers' requirements for developing therapies based on various animal cells.
Various Research Resources
BioVenic's veterinary cell therapy development solution draws on established therapies and incorporates a variety of approaches and techniques. Our internal and external research resources can assist clients in preclinical studies of veterinary cell therapy development.
BioVenic considers the key factors influencing the development of veterinary cell products and therapies. We offer comprehensive program customization and evaluation for researchers worldwide. From an engineering standpoint, we conduct genome and epigenome editing, synthetic biology, and biomaterial-mediated immunomodulation on the functional cells utilized in the therapy to enhance their therapeutic potential, safety, effectiveness, and accessibility. If you are working on a cell-based therapy for a disease in a companion animal or studying a specific type of functional cell in an animal, please contact us to discuss your project details and access exclusive solutions.